Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Nanomedicines Market Report, History and Forecast 2012-2025 By Manufacturers, Breakdown Data, Key Regions and Application

Sep-2018 | Published By : QYResearch | Category : Medical Devices | Pages : 94

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Nanomedicines Market Report, History and Forecast 2012-2025 By Manufacturers, Breakdown Data, Key Regions and Application

Sep-2018 | Published By : QYResearch | Category : Medical Devices | Pages : 94 | Format : PDF

This report focuses on the global Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicines development in United States, Europe and China.

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
In 2017, the global Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Abbott
    GE Healthcare
    Johnson & Johnson
    Merck
    Pfizer
    CombiMatrix
    Celgene
    Mallinckrodt
    Sigma-Tau Pharmaceuticals
    Teva Pharmaceutical
    Nanosphere
    UCB SA

Market segment by Type, the product can be split into
    Nanoparticles
    Nanoshells
    Nanotubes
    Nanodevices
    Others

Market segment by Application, split into
    Hospitals
    Clinics
    Research Institute

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Nanomedicines status, future forecast, growth opportunity, key market and key players.
    To present the Nanomedicines development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicines are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
<pre>Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Nanomedicines Market Size Growth Rate by Type (2013-2025) 1.4.2 Nanoparticles 1.4.3 Nanoshells 1.4.4 Nanotubes 1.4.5 Nanodevices 1.4.6 Others 1.5 Market by Application 1.5.1 Global Nanomedicines Market Share by Application (2013-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Research Institute 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Nanomedicines Market Size 2.2 Nanomedicines Growth Trends by Regions 2.2.1 Nanomedicines Market Size by Regions (2013-2025) 2.2.2 Nanomedicines Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Nanomedicines Market Size by Manufacturers 3.1.1 Global Nanomedicines Revenue by Manufacturers (2013-2018) 3.1.2 Global Nanomedicines Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Nanomedicines Market Concentration Ratio (CR5 and HHI) 3.2 Nanomedicines Key Players Head office and Area Served 3.3 Key Players Nanomedicines Product/Solution/Service 3.4 Date of Enter into Nanomedicines Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Nanomedicines Market Size by Type (2013-2018) 4.2 Global Nanomedicines Market Size by Application (2013-2018) 5 United States 5.1 United States Nanomedicines Market Size (2013-2018) 5.2 Nanomedicines Key Players in United States 5.3 United States Nanomedicines Market Size by Type 5.4 United States Nanomedicines Market Size by Application 6 Europe 6.1 Europe Nanomedicines Market Size (2013-2018) 6.2 Nanomedicines Key Players in Europe 6.3 Europe Nanomedicines Market Size by Type 6.4 Europe Nanomedicines Market Size by Application 7 China 7.1 China Nanomedicines Market Size (2013-2018) 7.2 Nanomedicines Key Players in China 7.3 China Nanomedicines Market Size by Type 7.4 China Nanomedicines Market Size by Application 8 Japan 8.1 Japan Nanomedicines Market Size (2013-2018) 8.2 Nanomedicines Key Players in Japan 8.3 Japan Nanomedicines Market Size by Type 8.4 Japan Nanomedicines Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Nanomedicines Market Size (2013-2018) 9.2 Nanomedicines Key Players in Southeast Asia 9.3 Southeast Asia Nanomedicines Market Size by Type 9.4 Southeast Asia Nanomedicines Market Size by Application 10 India 10.1 India Nanomedicines Market Size (2013-2018) 10.2 Nanomedicines Key Players in India 10.3 India Nanomedicines Market Size by Type 10.4 India Nanomedicines Market Size by Application 11 Central & South America 11.1 Central & South America Nanomedicines Market Size (2013-2018) 11.2 Nanomedicines Key Players in Central & South America 11.3 Central & South America Nanomedicines Market Size by Type 11.4 Central & South America Nanomedicines Market Size by Application 12 International Players Profiles 12.1 Abbott 12.1.1 Abbott Company Details 12.1.2 Company Description and Business Overview 12.1.3 Nanomedicines Introduction 12.1.4 Abbott Revenue in Nanomedicines Business (2013-2018) 12.1.5 Abbott Recent Development 12.2 GE Healthcare 12.2.1 GE Healthcare Company Details 12.2.2 Company Description and Business Overview 12.2.3 Nanomedicines Introduction 12.2.4 GE Healthcare Revenue in Nanomedicines Business (2013-2018) 12.2.5 GE Healthcare Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Nanomedicines Introduction 12.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2013-2018) 12.3.5 Johnson & Johnson Recent Development 12.4 Merck 12.4.1 Merck Company Details 12.4.2 Company Description and Business Overview 12.4.3 Nanomedicines Introduction 12.4.4 Merck Revenue in Nanomedicines Business (2013-2018) 12.4.5 Merck Recent Development 12.5 Pfizer 12.5.1 Pfizer Company Details 12.5.2 Company Description and Business Overview 12.5.3 Nanomedicines Introduction 12.5.4 Pfizer Revenue in Nanomedicines Business (2013-2018) 12.5.5 Pfizer Recent Development 12.6 CombiMatrix 12.6.1 CombiMatrix Company Details 12.6.2 Company Description and Business Overview 12.6.3 Nanomedicines Introduction 12.6.4 CombiMatrix Revenue in Nanomedicines Business (2013-2018) 12.6.5 CombiMatrix Recent Development 12.7 Celgene 12.7.1 Celgene Company Details 12.7.2 Company Description and Business Overview 12.7.3 Nanomedicines Introduction 12.7.4 Celgene Revenue in Nanomedicines Business (2013-2018) 12.7.5 Celgene Recent Development 12.8 Mallinckrodt 12.8.1 Mallinckrodt Company Details 12.8.2 Company Description and Business Overview 12.8.3 Nanomedicines Introduction 12.8.4 Mallinckrodt Revenue in Nanomedicines Business (2013-2018) 12.8.5 Mallinckrodt Recent Development 12.9 Sigma-Tau Pharmaceuticals 12.9.1 Sigma-Tau Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Nanomedicines Introduction 12.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2013-2018) 12.9.5 Sigma-Tau Pharmaceuticals Recent Development 12.10 Teva Pharmaceutical 12.10.1 Teva Pharmaceutical Company Details 12.10.2 Company Description and Business Overview 12.10.3 Nanomedicines Introduction 12.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2013-2018) 12.10.5 Teva Pharmaceutical Recent Development 12.11 Nanosphere 12.12 UCB SA 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details</pre>


 Latest Research Reports